193 related articles for article (PubMed ID: 37483565)
1. Clinical assessment of a low-cost, hand-held, smartphone-attached intraoral imaging probe for 5-aminolevulinic acid photodynamic therapy monitoring and guidance.
Khan S; Song B; Mallidi S; Li S; Liu H; Bilal Hussain MA; Siddiqui S; Khan AP; Akhtar K; Siddiqui SA; Hasan SA; Hopper C; Bown SG; Liang R; Hasan T; Celli JP
J Biomed Opt; 2023 Aug; 28(8):082809. PubMed ID: 37483565
[TBL] [Abstract][Full Text] [Related]
2. Clinical evaluation of smartphone-based fluorescence imaging for guidance and monitoring of ALA-PDT treatment of early oral cancer.
Khan S; Hussain MAB; Khan AP; Liu H; Siddiqui S; Mallidi S; Leon P; Daly L; Rudd G; Cuckov F; Hopper C; Bown SG; Akhtar K; Hasan SA; Siddiqui SA; Hasan T; Celli JP
J Biomed Opt; 2020 Apr; 25(6):1-10. PubMed ID: 32279466
[TBL] [Abstract][Full Text] [Related]
3. Development and evaluation of a low-cost, portable, LED-based device for PDT treatment of early-stage oral cancer in resource-limited settings.
Liu H; Daly L; Rudd G; Khan AP; Mallidi S; Liu Y; Cuckov F; Hasan T; Celli JP
Lasers Surg Med; 2019 Apr; 51(4):345-351. PubMed ID: 30168618
[TBL] [Abstract][Full Text] [Related]
4. Smartphone fluorescence imager for quantitative dosimetry of protoporphyrin-IX-based photodynamic therapy in skin.
Ruiz AJ; LaRochelle EPM; Gunn JR; Hull SM; Hasan T; Chapman MS; Pogue BW
J Biomed Opt; 2019 Dec; 25(6):1-13. PubMed ID: 31820594
[No Abstract] [Full Text] [Related]
5. Clinical evaluation of a mobile, low-cost system for fluorescence guided photodynamic therapy of early oral cancer in India.
Siddiqui SA; Siddiqui S; Hussain MAB; Khan S; Liu H; Akhtar K; Hasan SA; Ahmed I; Mallidi S; Khan AP; Cuckov F; Hopper C; Bown S; Celli JP; Hasan T
Photodiagnosis Photodyn Ther; 2022 Jun; 38():102843. PubMed ID: 35367616
[TBL] [Abstract][Full Text] [Related]
6. Fluorescence staining of oral cancer using a topical application of 5-aminolevulinic acid: fluorescence microscopic studies.
Leunig A; Mehlmann M; Betz C; Stepp H; Arbogast S; Grevers G; Baumgartner R
J Photochem Photobiol B; 2001 Apr; 60(1):44-9. PubMed ID: 11386680
[TBL] [Abstract][Full Text] [Related]
7. Identification and pharmacological modification of resistance mechanisms to protoporphyrin-mediated photodynamic therapy in human cutaneous squamous cell carcinoma cell lines.
Schary N; Novak B; Kämper L; Yousf A; Lübbert H
Photodiagnosis Photodyn Ther; 2022 Sep; 39():103004. PubMed ID: 35811052
[TBL] [Abstract][Full Text] [Related]
8. Comparing desferrioxamine and light fractionation enhancement of ALA-PpIX photodynamic therapy in skin cancer.
de Souza AL; Marra K; Gunn J; Samkoe KS; Kanick SC; Davis SC; Chapman MS; Maytin EV; Hasan T; Pogue BW
Br J Cancer; 2016 Sep; 115(7):805-13. PubMed ID: 27575852
[TBL] [Abstract][Full Text] [Related]
9. Improvement of the efficacy of 5-aminolevulinic acid-mediated photodynamic treatment in human oral squamous cell carcinoma HSC-4.
Yamamoto M; Fujita H; Katase N; Inoue K; Nagatsuka H; Utsumi K; Sasaki J; Ohuchi H
Acta Med Okayama; 2013; 67(3):153-64. PubMed ID: 23804138
[TBL] [Abstract][Full Text] [Related]
10. Pre-treatment protoporphyrin IX concentration in actinic keratosis lesions may be a predictive biomarker of response to aminolevulinic-acid based photodynamic therapy.
Kanick SC; Davis SC; Zhao Y; Sheehan KL; Hasan T; Maytin EV; Pogue BW; Chapman MS
Photodiagnosis Photodyn Ther; 2015 Dec; 12(4):561-6. PubMed ID: 26480810
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the potential of Delta-aminolevulinic acid for simultaneous detection of bioburden and anti-microbial photodynamic therapy of MRSA infected wounds in Swiss albino mice.
Sahu K; Krishna H; Shrivastava R; Majumdar A; Chowdhury A; Chakraborty S; Majumder SK
J Photochem Photobiol B; 2024 May; 254():112892. PubMed ID: 38513542
[TBL] [Abstract][Full Text] [Related]
12. 5-Aminolevulinic acid (ALA)-induced protoporphyrin IX fluorescence and photodynamic effects in the rat bladder: an in vivo study comparing oral and intravesical ALA administration.
Chang SC; Buonaccorsi G; MacRobert AJ; Bown SG
Lasers Surg Med; 1997; 20(3):254-64. PubMed ID: 9138254
[TBL] [Abstract][Full Text] [Related]
13. The effect of an iron chelating agent on protoporphyrin IX levels and phototoxicity in topical 5-aminolaevulinic acid photodynamic therapy.
Choudry K; Brooke RC; Farrar W; Rhodes LE
Br J Dermatol; 2003 Jul; 149(1):124-30. PubMed ID: 12890205
[TBL] [Abstract][Full Text] [Related]
14. Sublingual administration of 5-aminolevulinic acid for laser-induced photodiagnostics and photodynamic therapy of oral cavity and larynx cancers.
Alekseeva PM; Efendiev KT; Shiryaev AA; Rusakov MA; Simonova MS; Samoylova SI; Fatyanova AS; Reshetov IV; Loschenov VB
Photodiagnosis Photodyn Ther; 2021 Jun; 34():102289. PubMed ID: 33839329
[TBL] [Abstract][Full Text] [Related]
15. Multispectral autofluorescence imaging for detection of cervical lesions: A preclinical study.
Bae SJ; Lee DS; Berezin V; Kang U; Lee KH
J Obstet Gynaecol Res; 2016 Dec; 42(12):1846-1853. PubMed ID: 27748558
[TBL] [Abstract][Full Text] [Related]
16. Iron chelation promotes 5-aminolaevulinic acid-based photodynamic therapy against oral tongue squamous cell carcinoma.
Qin J; Zhou C; Zhu M; Shi S; Zhang L; Zhao Y; Li C; Wang Y; Wang Y
Photodiagnosis Photodyn Ther; 2020 Sep; 31():101907. PubMed ID: 32619712
[TBL] [Abstract][Full Text] [Related]
17. Small molecule kinase inhibitors enhance aminolevulinic acid-mediated protoporphyrin IX fluorescence and PDT response in triple negative breast cancer cell lines.
Palasuberniam P; Kraus D; Mansi M; Howley R; Braun A; Myers K; Chen B
J Biomed Opt; 2021 Sep; 26(9):. PubMed ID: 34545713
[TBL] [Abstract][Full Text] [Related]
18. Topical methotrexate pretreatment enhances the therapeutic effect of topical 5-aminolevulinic acid-mediated photodynamic therapy on hamster buccal pouch precancers.
Yang DF; Lee JW; Chen HM; Hsu YC
J Formos Med Assoc; 2014 Sep; 113(9):591-9. PubMed ID: 24811932
[TBL] [Abstract][Full Text] [Related]
19. Aminolevulinic Acid-Based Tumor Detection and Therapy: Molecular Mechanisms and Strategies for Enhancement.
Yang X; Palasuberniam P; Kraus D; Chen B
Int J Mol Sci; 2015 Oct; 16(10):25865-80. PubMed ID: 26516850
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of ABCG2 transporter by lapatinib enhances 5-aminolevulinic acid-mediated protoporphyrin IX fluorescence and photodynamic therapy response in human glioma cell lines.
Mansi M; Howley R; Chandratre S; Chen B
Biochem Pharmacol; 2022 Jun; 200():115031. PubMed ID: 35390338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
